Skip to main content
menu sluit menu
Home Home
Login
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
User tools menu
User tools menu
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
Follow IVIS
  • Twitter
  • Facebook
Support IVIS

Breadcrumb

  1. Home
  2. Library
  3. American Association of Equine Practitioners
  4. AAEP Resort Symposium - Hawaii, 2015
  5. New Biologic Therapies for Joint Disease
AAEP Resort Hawaii 2015
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Comments
Share:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter

New Biologic Therapies for Joint Disease

Author(s):
McIlwraith C.W.
In: AAEP Resort Symposium - Hawaii, 2015 by American Association of Equine Practitioners
Updated:
JAN 30, 2015
Languages:
  • EN
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
SHARE:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter
    Read

    Take Home Message: Newer biologically based therapies involve two complementary approaches: 1) inhibiting cartilage breakdown (catabolism) and 2) enhancing cartilage synthesis (anabolism). Currently used therapies include autologous xonditionedserum(ACS), which provides therapeutic effect by inhibiting interleukin-1 (IL-1) as well as increasing the anabolic growth factor concentrations. Its effectiveness as an intraarticular therapy has been defined. Pl atelet rich plasma (PRP) has bee n used intraarticularly but still requires further evidence for proof of efficacy.

    I. INTRODUCTION

    Improved understanding of critical mediators in equine traumatic arthritis and osteoarthritis (OA) has led to the identification of multiple possible targets for therapy.1 Biologically based therapies can be grouped into two complementary approaches:

    1. Inhibiting cartilage breakdown (catabolism).
    2. Enhancing cartilage synthesis (anabolism) (Fig. 1).2

    Although there are multiple possible targets for inhibiting catabolism, most attention has been paid to IL-1 as well as metalloproteinases and aggrecanase.

    This paper reviews the current use of the autologous conditioned serum products,1,2 and PRP in treating joint and other soft tissue injuries and disease in the horse.

    II. AUTOLOGOUS CONDITIONED SERUMA,B

    It has been demonstrated using intra-articular gene therapy with interleukin-1 receptor antagonist (IL-1ra) and an adenoviral vector that OA can be prevented proving the importance of IL-1 in the equine OA cascade (Fig. 2).3,4 Specific anticytokine therapy in general has been a new approach for treating diseases such as rheumatoid arthritis, but because of problems with reactivity to the adenoviral vector, gene therapy is still not a reality. There is no specific IL-1ra serum and initially having the trade name Orthokine® has a significant increase in IL-1ra as one effect of the process.5,6 The principle is that the patient’s blood is incubated in a container with coated beads for 24 hours, centrifuged and then the resulting “conditioned” serum injected intra-articularly.
     

    Fig. 1. Diagram of homeostatic pathways that can represent potential ways

    Fig. 1. Diagram of homeostatic pathways that can represent potential ways of endogenously manipulating articular cartilage.

    Fig. 2. Diagram of IL-1 activation of MMP

    Fig. 2. Diagram of IL-1 activation of MMP, agg recanase and PGE2 release acting through I L-1 receptors on the cell membrane.

    Orthokine was tested in horses in Europe initially by Dr Thomas Weinbergerc and he found that it was particularly beneficial in OA of the distal interphalangeal joint not responding to triamcinolone and hyaluronan (HA). Work with human blood examining the IRAP and IRAP II systems shows increased IL-1ra as well as IGF-1 and TGF-β but also increases in IL-1 and TNF-α.7 This product was evaluated using the Colorado State University (CSU) experimental
    model of equine OA.8 In a 16-horse study with unilateral OA, eight horses received three injections of IRAP into the OA joint and the other eight horses received intra-articular saline at the same time. Treatment was initiated at two weeks and a total of three treatments administered at weekly intervals. Horses treated with ACS were observed to have significantly reduced lameness in OA limbs, even five weeks after the last treatment, compared with placebo-treated horses.8 There was also a significant reduction in synovial membrane inflammation in treated compared with placebo OA joints at day 70 and a trend for improvement in cartilage gross score and proteoglycan staining in ACS treated OA joints compared with placebo treated OA joints.

    When Orthogen discontinued Arthrex as its licensee in the United States, Arthrex developed IRAP II. Comparative cytokine profiles of IRAP and IRAP II using equine blood were then performed in the author’s laboratory and have been reported.7 Both products had significant increases in IL-1ra concentrations, but the IRAP II system was significantly superior to IRAP. Of more importance, it was noted that the IL-1ra:IL-1 ratio was significantly better with IRAP II. The production of the growth factors IGF-1 and TGF-β were both increased to about double the levels of serum with no difference between the products. It was also noted that IRAP produced significantly more TNFα than IRAP II and this was considered to be a significant issue because of the known deleterious effects of TNFα.

    III. PRACTICAL USE OF IRAP IN THE TREATMENT OF EQUINE JOINT DISEASE

    The author has limited his use of IRAP to joint disease because this is where we have demonstrated efficacy and generally recommends the use of PRP products in tendons and ligaments (however, there is evidence in humans for usefulness for PRP in OA as well). Based on our research findings, the following are recommended volumes for individual joints:

    • Carpal, fetlock, distal interphalangeal joints and tendon sheaths – 6mL
    • Stifles – 10-12mL

    Based on a recent retrospective study of equine veterinarians in the United States,9 the use of intra-articular autologous conditioned serum (IRAP and IRAP II products) was greater with sport horse veterinarians compared with racehorse veterinarians. Some of this difference is attributable to costs but use is greater in racehorses outside the United States because of longer withdrawal times for intra-articular corticosteroids.

    IV. PLATELET-RICH PLASMA

    The term PRP has become a buzzword in the mainstream media – especially in the treatment of high-profile human athletes. Ultimately, veterinarians are responsible for interpreting the science, determining the appropriate indications and counseling patients about what PRP can and cannotaccomplish.

    PRP has been advocated as a way to introduce increased concentrations of growth factors and other bioactive molecules to injured tissues in an attempt to optimize the local healing environment. It has been used extensively in dental and cosmetic surgery for almost 30 years. Recently, it has become increasingly utilized for a variety of orthopaedic (musculoskeletal) applications.10,11 There have been various definitions of PRP, but the consensus now is that the product should have an increase in platelet content over the level in blood. The initial enthusiasm for PRP was based on growth factors within the α-granules including transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), insulin-like growth factor-1 and -2 (IGF-1 and -2), fibroblast growth factor (FGF), epidermal growth factor (EGF) and endothelial cell growth factor. There are a number of other bioactive factors in PRP contained in dense granules of platelets10 and there is an emerging paradigm that more than just platelets are playing a role in PRP.12

    The basic principle of PRP is the selective separation of anticoagulated whole blood (plasmapheresis) via centrifugation. There are differences in the commercial systems with single spin and double spin systems with consequently different levels of platelet concentration (as well as different levels of leukocyte concentration).11

    V. THE USE OF PRP TO TREAT JOINT DISEASE

    The use of PRP to treat joint disease in the horse is increasing. At CSU’s Orthopaedic Research Center (ORC) we have tended to recommend IRAP and IRAP II for joints and PRP (or autologous conditioned plasma (ACP)) for treatment of tendon and ligamentous injuries. However, good clinical results with OA in humans have been reported, 13 and recent in vitro work in our laboratory has shown beneficial effects on cartilage metabolism.14 Also, when administered via intra-articular injection in ovine subjects, PRP increased cartilage healing15 as well as superior healing in a meniscal defect model.16 In a comparative study in human OA, PRP was superior to HA but randomized,13 controlled studies are needed. 

    VI. PLATELET VERSUS WHITE CELL DEBATE

    Initial studies of the bioactive molecules in PRP focused on growth factor concentrations that are related to platelet numbers. [...]

    View full text
    Back to Table of Contents
    Add to My Library
    Close
    Would you like to add this to your library?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    Comments (0)

    Ask the author

    0 comments
    Submit
    Close
    Would to like to further discuss this item?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    About

    How to reference this publication (Harvard system)?

    McIlwraith, C. (2015) “New Biologic Therapies for Joint Disease”, AAEP Resort Symposium - Hawaii, 2015. Available at: https://www.ivis.org/library/aaep/aaep-resort-symposium-hawaii-2015/new-biologic-therapies-for-joint-disease (Accessed: 06 December 2023).

    Author(s)

    • C. Wayne McIlwraith

      McIlwraith C.W.

      Professor
      BVSc PhD FRCVS DSc DMV (hc) Dipl ACVS
      Equine Orthopedic Research Laboratory, College of Veterinary Medicine and Biomedical Sciences, Colorado State University
      Read more about this author

    Copyright Statement

    © All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.
    Related Content

    Readers also viewed these publications

    • Journal Issue

      Veterinary Evidence - Vol 8 N°3, Jul-Sep 2023

      In: Veterinary Evidence
      NOV 04, 2023
    • Journal Issue

      Veterinary Evidence - Vol 8 N°2, Apr-Jun 2023

      In: Veterinary Evidence
      JUN 26, 2023
    • Proceeding

      BEVA - Annual Congress - Liverpool, 2022

      By: British Equine Veterinary Association
      MAR 20, 2023
    • Journal Issue

      Veterinary Evidence - Vol 8 N°1, Jan-Mar 2023

      In: Veterinary Evidence
      MAR 19, 2023
    • Proceeding

      AVEF - Conférence Annuelle - Reims, 2022

      By: Association des Vétérinaires Équins Français
      MAR 03, 2023
    • Proceeding

      EEHNC - Virtual Congress - 2021

      By: European Equine Health and Nutrition Congress
      FEB 09, 2023
    • Proceeding

      SFT - Theriogenology Annual Conference - Bellevue, 2022

      By: Society for Theriogenology
      JAN 10, 2023
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(4), Dec. 2022

      In: Israel Journal of Veterinary Medicine
      DEC 31, 2022
    • Proceeding

      ACVIM & ECEIM - Consensus Statements

      By: American College of Veterinary Internal Medicine
      NOV 11, 2022
    • Chapter

      Tibia and Tarsus

      In: Current Techniques in Small Animal Surgery (5th Edition)
      NOV 07, 2022
    • Chapter

      Femur and Stifle Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 28, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°2, Apr-Jun 2022

      In: Veterinary Evidence
      OCT 07, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022

      In: Veterinary Evidence
      OCT 04, 2022
    • Chapter

      Scapula and Shoulder Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 05, 2022
    • Chapter

      Bone Grafts and Implants

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 03, 2022
    • Chapter

      External Skeletal Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 28, 2022
    • Chapter

      Plate-Rod Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 18, 2022
    • Chapter

      Fixation with Screws and Bone Plates

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 15, 2022
    • Chapter

      Interlocking Nailing of Canine and Feline Fractures

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 11, 2022
    • Chapter

      Fixation with Pins and Wires

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 07, 2022
    • Journal Issue

      Veterinary Practice Management Articles - Veterinary Focus

      In: Veterinary Focus
      AUG 05, 2022
    • Proceeding

      Lameness in Ruminants - International Symposium and Conference - USA 2022

      By: International Conference on Lameness in Ruminants
      AUG 01, 2022
    • Chapter

      Nutrition

      In: The Clinical Companion of the Donkey (2nd Edition)
      JUL 09, 2022
    • Chapter

      Pharmacology and Therapeutics

      In: The Clinical Companion of the Donkey (2nd Edition)
      JUL 03, 2022
    • Chapter

      Sedation, Anaesthesia and Analgesia

      In: The Clinical Companion of the Donkey (2nd Edition)
      JUN 05, 2022
    • Load more
    Provided by:
    AAEP - American Association of Equine Practitioners

    The AAEP represents nearly 9,300 veterinarians and veterinary students in 61 countries who cover a broad range of equine disciplines, breeds and associations. The AAEP is primary resource for education, professional development and ethical standards for its members. The AAEP and its members are recognized as the voice and authority for the health and welfare of the horse. The AAEP conducts regular strategic planning every three to four years in order to establish priorities and set direction for the association over the current planning horizon.  The AAEP is a respected source of information for influencing public policy.  

    Learn more
    Back To Top
    Become a member of IVIS and get access to all our resources
    Create an account
    Sign in
    Leading the way in providing veterinary information
    About IVIS
    • Mission
    • What we do
    • Who we are
    Need help?
    • Contact
    Follow IVIS
    • Twitter
    • Facebook
    International Veterinary Information Service (IVIS) is a not-for-profit organization established to provide information to veterinarians, veterinary students, technicians and animal health professionals worldwide using Internet technology.
    Support IVIS
    © 2023 International Veterinary Information Service
    • Disclaimer
    • Privacy Policy